Concepedia

John Breen

JB

9

Publications

567

Citations

9

H-Index

2007

Active since

Affiliations

AstraZeneca (United States)(Current)

AstraZeneca (United Kingdom)

John Breen is an author at AstraZeneca (United States) specializing in drug discovery, pharmacology, and medicine.

Top concepts

Publications per year

2007–2016

9

Publications

9

Characterization of seed‐specific benzoyloxyglucosinolate mutations in <i>Arabidopsis thaliana</i>

Daniel J. Kliebenstein, John C. D’Auria, Aditi S. Behere et al. · The Plant Journal · 2007 · 101 citations

Novel N-Linked Aminopiperidine Inhibitors of Bacterial Topoisomerase Type II: Broad-Spectrum Antibacterial Agents with Reduced hERG Activity

Folkert Reck, Richard A. Alm, Patrick Brassil et al. · Journal of Medicinal Chemistry · 2011 · 101 citations · Full text

, , +21

Novel N-Linked Aminopiperidine Inhibitors of Bacterial Topoisomerase Type II with Reduced p<i>K</i><sub>a</sub>: Antibacterial Agents with an Improved Safety Profile

Folkert Reck, Richard A. Alm, Patrick Brassil et al. · Journal of Medicinal Chemistry · 2012 · 88 citations · Full text

Antibacterial Inhibitors of Gram-Positive Thymidylate Kinase: Structure–Activity Relationships and Chiral Preference of a New Hydrophobic Binding Region

Sameer Kawatkar, Thomas A. Keating, N.B. Olivier et al. · Journal of Medicinal Chemistry · 2014 · 61 citations

, , +23

Structure Based Design of Non-Natural Peptidic Macrocyclic Mcl-1 Inhibitors

Jeffrey W. Johannes, Stephanie M. Bates, Carl Beigie et al. · ACS Medicinal Chemistry Letters · 2016 · 60 citations · Full text

Rows per page

1–5 of 9